KAZIA THERAPEUTICS-SPON ADR (KZIA)
US48669G1058 - ADR
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | N/A | N/A | N/A | -12.47M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | 1.08M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | -300.00K | |||
| Change In Working Capital | -9.58M | 23.11K | 24.96K | 1.02M | -8.81M | |||
| Other non cash items | N/A | N/A | N/A | N/A | 900.00K | |||
| OPERATING CASH FLOW | -9.58M | -15.16M | -22.76M | -9.11M | -8.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Investing Activity | 0.00 | 0.00 | -2.36M | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | 0.00 | 0.00 | -2.36M | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 405.00K | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 5.58M | 12.97M | 3.73M | 28.11M | 12.14M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 5.99M | 12.97M | 3.73M | 28.11M | 12.14M | |||
| Exchange Rate Effect | 12.00K | 64.25K | 1.18M | -175.62K | 0.00 | |||
| CHANGE IN CASH | -3.58M | -2.12M | -20.23M | 18.82M | 3.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.58M | -15.16M | -22.76M | -9.11M | -8.81M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -9.58M | -15.16M | -22.76M | -9.11M | -8.81M | |||
All data in AUD